Showing results (151-160 of 608) with videos related to
Sort By:
Pageof 61
Antimicrobial Agents and Chemotherapy|August 9, 2021
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of V-7404 in Healthy Adult VolunteersMartin K Kankam, Jennifer M Burns, Marc S Collett, et al.Antimicrobial Agents and Chemotherapy|December 24, 2008
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitorsLotte Coelmont, Suzanne Kaptein, Jan Paeshuyse, et al.Antimicrobial Agents and Chemotherapy|January 25, 2003
Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in micePieter Leyssen, Christian Drosten, Marcus Paning, et al.Journal of Natural Products|December 11, 2012
Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of Chikungunya virus replicationMélanie Bourjot, Leen Delang, Van Hung Nguyen, et al.Antiviral Research|July 25, 2017
Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antiviralsKristina Lanko, Kristel Eggermont, Abdulsamie Patel, et al.Plos Neglected Tropical Diseases|May 11, 2016
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection ModelJoanna Zmurko, Rafael E Marques, Dominique Schols, et al.Antiviral Research|April 7, 2011
Towards the design of combination therapy for the treatment of enterovirus infectionsHendrik Jan Thibaut, Pieter Leyssen, Gerhard Puerstinger, et al.Antiviral Research|January 1, 2017
Protein kinases C as potential host targets for the inhibition of chikungunya virus replicationRana Abdelnabi, Siti Naqiah Amrun, Lisa F P Ng, et al.Antiviral Research|October 24, 2006
2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virusNesya Goris, Armando De Palma, Jean-François Toussaint, et al.Antiviral Research|September 3, 2013
Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivativeNilda V Ayala-Nuñez, Patsaporn Jarupathirun, Suzanne J F Kaptein, et al.Pageof 61